We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AMIWOK, AMIKACIN WOCKHARDT (Wockhardt Bio Pty Ltd)
Product name
AMIWOK, AMIKACIN WOCKHARDT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
151 working days (255)
Active ingredients
amikacin (as sulfate)
Registration type
New generic medicine
Indication
AMIWOK, AMIKACIN WOCKHARDT (solution for injection) is indicated in the:
- short-term treatment of serious infections caused by susceptible strains of Gram-negative bacteria;
- treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.